0 antall prosjekter

PES2020-Prosj.etabl.støtte H2020

ARCHER: Antimicrobial coated bReakaway variable lumen Connector for intravenous tHERapy

The overall aim of the ARCHER project is to develop the first antimicrobial impregnated breakaway connection device that prevents central line associated blood stream infections in patients undergoing central venous catheter intravenous (IV) therapy, decreasing healthcare expenses, and reducing p...

Tildelt: kr 79 999

Prosjektperiode: 2021-2021

Sted: Troms - Romsa - Tromssa

PES2020-Prosj.etabl.støtte H2020

Late pre-clinical and Phase 1a studies for a promising drug lead that may drastically improve cognition in individuals with Down Syndrome.

Currently, there are no approved treatments for the primary symptoms of DS, and only limited treatments for dementia in ageing individuals. Dual-specificity tyrosine phosphorylation regulated kinase 1A (DYRK1A) is an essential factor in Down Syndrom. DYRK1A regulates differentiation of neuronal ...

Tildelt: kr 74 999

Prosjektperiode: 2018-2018

Sted: Akershus

BIA-Brukerstyrt innovasjonsarena

A novel antimicrobial agent for treatment of infections caused by drug-resistant bacteria, preclinical and early phase clinical studie

The present proposal covers preclinical exploratory and Phase I/IIa development programme of LTX-109. The proposal encompasses our internal development program as well as the establishment and management of external production and development programs. L ytix Biopharma AS develop novel antimicro...

Tildelt: kr 8,3 mill.

Prosjektperiode: 2009-2011

Sted: Oslo